Abeona Stock Performance

ABEO
 Stock
  

USD 3.04  0.08  2.70%   

The firm shows a Beta (market volatility) of 1.5075, which signifies a somewhat significant risk relative to the market. Let's try to break down what Abeona's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Abeona Therapeutics will likely underperform. Even though it is essential to pay attention to Abeona Therapeutics historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Abeona Therapeutics exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Abeona Therapeutics has an expected return of -0.28%. Please be advised to confirm Abeona Therapeutics potential upside, rate of daily change, and the relationship between the sortino ratio and skewness to decide if Abeona Therapeutics performance from the past will be repeated at some point in the near future.
  
Abeona Performance
0 of 100
Over the last 90 days Abeona Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in November 2022. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more

Abeona Price Channel

Quick Ratio2.54
Fifty Two Week Low0.2700
Target High Price100.00
Fifty Two Week High29.5000
Target Low Price15.00

Abeona Therapeutics Relative Risk vs. Return Landscape

If you would invest  408.00  in Abeona Therapeutics on July 3, 2022 and sell it today you would lose (104.00)  from holding Abeona Therapeutics or give up 25.49% of portfolio value over 90 days. Abeona Therapeutics is currently does not generate positive expected returns and assumes 6.092% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than Abeona, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Abeona Therapeutics is expected to under-perform the market. In addition to that, the company is 5.32 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.1 per unit of volatility.

Abeona Therapeutics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Abeona Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abeona Therapeutics, and traders can use it to determine the average amount a Abeona Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0464

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsABEO
Estimated Market Risk
 6.09
  actual daily
 
 52 %
of total potential
 
5252
Expected Return
 -0.28
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.05
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Abeona Therapeutics is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abeona Therapeutics by adding it to a well-diversified portfolio.

About Abeona Therapeutics Performance

To evaluate Abeona Therapeutics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Abeona Therapeutics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Abeona Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Abeona Therapeutics market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Abeona's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York. Abeona Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 90 people.

Things to note about Abeona Therapeutics

Checking the ongoing alerts about Abeona Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abeona Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Abeona Therapeutics Alerts

Equity Alerts and Improvement Suggestions

Abeona Therapeutics generated a negative expected return over the last 90 days
Abeona Therapeutics has high historical volatility and very poor performance
Abeona Therapeutics is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 3.35 M. Net Loss for the year was (89.72 M) with loss before overhead, payroll, taxes, and interest of (299 K).
Abeona Therapeutics currently holds about 31.32 M in cash with (65.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.33, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from MacroaxisInsider: Acquisition by Wuchterl Donald A of 13400 shares of Abeona Therapeutics subject to Rule 16b-3
Please continue to Trending Equities. Note that the Abeona Therapeutics information on this page should be used as a complementary analysis to other Abeona Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Abeona Stock analysis

When running Abeona Therapeutics price analysis, check to measure Abeona Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abeona Therapeutics is operating at the current time. Most of Abeona Therapeutics' value examination focuses on studying past and present price action to predict the probability of Abeona Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abeona Therapeutics' price. Additionally, you may evaluate how the addition of Abeona Therapeutics to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Abeona Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Abeona Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.